ResearcherPennsylvania State UniversityNo recent work listed
Mark A. Kester
Matched on ORCID iD 0000-0001-8231-7025; OpenAlex author ID A5111408531. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2011: 1 paper · 2012: none · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 2 papers · 2018: 1 paper
Papers 7
- Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages. Co-author DOI 10.1371/journal.pone.0206759↗
- Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic ca… Co-author DOI 10.1016/j.nano.2017.06.017↗
- A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1089/nat.2016.0621↗
- Ceramide 1-phosphate regulates cell migration and invasion of human pancreatic cancer cells. Co-author DOI 10.1016/j.bcp.2015.12.009↗
- Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat. Co-author DOI 10.1007/s10620-014-3201-8↗
- Altered sphingolipid metabolism in patients with metastatic pancreatic cancer. Co-author DOI 10.3390/biom3030435↗
- Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer. Last author DOI 10.4161/cbt.12.7.15971↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Todd E. Fox · 5 shared papers, 2011–2018 · strength 0.26
- Paper Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages. DOI 10.1371/journal.pone.0206759↗
- Paper Ceramide 1-phosphate regulates cell migration and invasion of human pancreatic cancer cells. DOI 10.1016/j.bcp.2015.12.009↗
- Paper Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanopart… DOI 10.1016/j.nano.2017.06.017↗
- Gail L. Matters · 4 shared papers, 2014–2018 · strength 0.25
- Paper Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages. DOI 10.1371/journal.pone.0206759↗
- Paper A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma. DOI 10.1089/nat.2016.0621↗
- Paper Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanopart… DOI 10.1016/j.nano.2017.06.017↗
- Gary A. Clawson · 3 shared papers, 2017–2018 · strength 0.21
- Paper Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages. DOI 10.1371/journal.pone.0206759↗
- Paper A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma. DOI 10.1089/nat.2016.0621↗
- Paper Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanopart… DOI 10.1016/j.nano.2017.06.017↗
- Thomas Abraham · 3 shared papers, 2017–2018 · strength 0.21
- Paper Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages. DOI 10.1371/journal.pone.0206759↗
- Paper A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma. DOI 10.1089/nat.2016.0621↗
- Paper Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanopart… DOI 10.1016/j.nano.2017.06.017↗
- Samuel S. Linton · 3 shared papers, 2017–2018 · strength 0.21
- Paper Tumor-promoting effects of pancreatic cancer cell exosomes on THP-1-derived macrophages. DOI 10.1371/journal.pone.0206759↗
- Paper A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma. DOI 10.1089/nat.2016.0621↗
- Paper Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanopart… DOI 10.1016/j.nano.2017.06.017↗
- Jill Palmer Smith · 3 shared papers, 2014–2017 · strength 0.16
- Paper A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma. DOI 10.1089/nat.2016.0621↗
- Paper Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanopart… DOI 10.1016/j.nano.2017.06.017↗
- Paper Cholecystokinin mediates progression and metastasis of pancreatic cancer associated with dietary fat. DOI 10.1007/s10620-014-3201-8↗
- James H. Adair · 2 shared papers, 2017 · strength 0.12
- Welley Siu Loc · 2 shared papers, 2017 · strength 0.12
- Yixing Jiang · 2 shared papers, 2011–2013 · strength 0.06
- Io-Guané Rivera · 1 shared paper, 2016 · strength 0.06
- Antonio Gómez‐Muñoz · 1 shared paper, 2016 · strength 0.06
- Keping Xie · 1 shared paper, 2013 · strength 0.04
- Myles C. Cabot · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.